Last reviewed · How we verify
NCT04597827: META-DEM
Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease
trial testing Metacognition tests in Semantic Dementia in 40 participants. Completed in 27 April 2022.
27 April 2022
Quick facts
| Lead sponsor | University Hospital, Grenoble |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 16 October 2020 |
| Primary completion | 27 April 2022 |
| Estimated completion | 27 April 2022 |
| Sites | 7 locations across France, Switzerland |
Drugs / interventions tested
- Metacognition tests
Conditions studied
- Semantic Dementia — all drugs for Semantic Dementia →
- Alzheimer Disease — all drugs for Alzheimer Disease →
- Healthy — all drugs for Healthy →
Sponsor
University Hospital, Grenoble
Who can join
Eligibility, any sex, with Semantic Dementia or Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims at exploring patients' ability to monitor their own memory performance depending on their primary deficit and the type of memory involved in the criterion task. The goal is to evaluate if semantic dementia (SD) and Alzheimer's disease (AD) differently affect patients' awareness of their memory abilities.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04597827
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Semantic Dementia
Currently open trials in the same condition.
- NCT05800028 — Memory and Social Interactions · recruiting
- NCT05184569 — Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology · Phase 1 · recruiting
- NCT04881617 — Treatment for Speech and Language in Primary Progressive Aphasia · NA · active not recruiting
Other University Hospital, Grenoble trials
Trials by the same sponsor.
- NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
- NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
- NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
- NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
- NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04597827 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
- Last refreshed: 7 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04597827.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing